Medistim ASA (OSL:MEDI)

Market Cap	4.18B
Revenue (ttm)	603.92M
Net Income (ttm)	122.88M
Shares Out	18.26M
EPS (ttm)	6.71
PE Ratio	34.13
Forward PE	32.26
Dividend	6.00 (2.75%)
Ex-Dividend Date	May 9, 2025

Volume	34,796
Average Volume	7,987
Open	216.00
Previous Close	218.00
Day's Range	216.00 - 234.00
52-Week Range	130.00 - 237.00
Beta	1.01
RSI	57.04
Earnings Date	Aug 20, 2025

About Altus Power

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 154
• Stock Exchange: Oslo Børs
• Ticker Symbol: MEDI

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.